CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
101 hedge funds and large institutions have $42.7M invested in Clovis Oncology, Inc. in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 24 closing their positions.
Holders
101
Holders Change
-12
Holders Change %
-10.62%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
23
Reduced
36
Closed
24
Calls
$4.99M
Puts
$2.39M
Net Calls
+$2.61M
Net Calls Change
+$203K
Top Buyers
| 1 |
QF
1
QVT Financial
New York
|
$4.2M |
| 2 |
ABG
2
Ally Bridge Group
New York
|
$635K |
| 3 |
N
3
Natixis
Paris,
France
|
$600K |
| 4 |
IA
4
IFP Advisors
Tampa,
Florida
|
$477K |
| 5 |
GCP
5
GSA Capital Partners
London,
United Kingdom
|
$475K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$1.16M |
| 2 |
E
2
Ergoteles
New York
|
$0 |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$12.1M |
| 4 |
4
BlackRock
New York
|
$4.8M |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$601K |
